Showing results (101-110 of 114) with videos related to
Sort By:
Pageof 12
Cancer|December 20, 2011
A study of circulating interleukin 10 in prognostication of unresectable hepatocellular carcinomaStephen L Chan, Frankie K F Mo, Cesar S C Wong, et al.Liver International : Official Journal of the International Association for the Study of the Liver|August 9, 2016
Systematic evaluation of circulating inflammatory markers for hepatocellular carcinomaStephen L Chan, Anthony W H Chan, Allen K C Chan, et al.Archives of Pathology & Laboratory Medicine|April 4, 2008
Proteomic comparison of nasopharyngeal cancer cell lines C666-1 and NP69 identifies down-regulation of annexin II and beta2-tubulin for nasopharyngeal carcinomaCharles M L Chan, S C Cesar Wong, Money Y Y Lam, et al.Clinical Chemistry|June 29, 2002
Quantification and utility of monosialylated alpha-fetoprotein in the diagnosis of hepatocellular carcinoma with nondiagnostic serum total alpha-fetoproteinTerence C W Poon, Tony S K Mok, Anthony T C Chan, et al.Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|January 6, 2018
Efficacy, Safety, and Pharmacokinetics of Axitinib in Nasopharyngeal Carcinoma: A Preclinical and Phase II Correlative StudyEdwin P Hui, Brigette B Y Ma, Herbert H F Loong, et al.Journal of Hepatology|December 16, 2014
A CCRK-EZH2 epigenetic circuitry drives hepatocarcinogenesis and associates with tumor recurrence and poor survival of patientsHai Feng, Zhuo Yu, Yuan Tian, et al.British Journal of Cancer|March 3, 2011
Clinical significance of CDX2-positive circulating tumour cells in colorectal cancer patientsS C C Wong, S S M Ng, M T Cheung, et al.Cancer Cell|March 7, 2025
Fragmentomics profiling and quantification of plasma Epstein-Barr virus DNA enhance prediction of future nasopharyngeal carcinomaW K Jacky Lam, Guannan Kang, Charles M L Chan, et al.JHEP Reports : Innovation in Hepatology|January 26, 2026
Pembrolizumab and stereotactic body radiotherapy combined in advanced hepatocellular carcinoma post sorafenib - A phase II trial (PEMRAD)Grainne M O'Kane, Aruz Mesci, Raymond W Jang, et al.Annals of Oncology : Official Journal of the European Society for Medical Oncology|May 1, 2022
Improved risk stratification of nasopharyngeal cancer by targeted sequencing of Epstein-Barr virus DNA in post-treatment plasmaD C T Chan, W K J Lam, E P Hui, et al.Pageof 12